Microbot Medical Inc Stock Nasdaq
Equities
US59503A1051
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 12.46M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.32% |
Managers | Title | Age | Since |
---|---|---|---|
Harel Gadot
CEO | Chief Executive Officer | 52 | 88-08-01 |
Rachel Vaknin
DFI | Director of Finance/CFO | 45 | 21-12-31 |
Chief Tech/Sci/R&D Officer | - | Nov. 30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Burell
BRD | Director/Board Member | 59 | 16-11-27 |
Director/Board Member | 66 | 17-12-11 | |
Tal Wenderow
BRD | Director/Board Member | 50 | 20-07-31 |
1st Jan change | Capi. | |
---|---|---|
-1.42% | 41.52B | |
+42.15% | 39.9B | |
+1.97% | 38.83B | |
-14.19% | 26.05B | |
+1.82% | 23.78B | |
-24.55% | 18.26B | |
-4.07% | 11.65B | |
+21.36% | 11.53B | |
+8.20% | 11.2B |